The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Amgen; Celgene; Takeda
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma (IFM 2012-03).
 
Arthur Bobin
No Relationships to Disclose
 
Guillemette Fouquet
No Relationships to Disclose
 
Alain Duhamel
No Relationships to Disclose
 
Salomon Manier
No Relationships to Disclose
 
Lionel Karlin
No Relationships to Disclose
 
Brigitte Kolb
No Relationships to Disclose
 
Mourad Tiab
No Relationships to Disclose
 
Carla Araujo
No Relationships to Disclose
 
Nathalie Meuleman
No Relationships to Disclose
 
Jean-Valère Malfuson
No Relationships to Disclose
 
Pascal Bourquard
No Relationships to Disclose
 
Pascal Lenain
No Relationships to Disclose
 
Arnaud Jaccard
No Relationships to Disclose
 
Karim Belhadj
No Relationships to Disclose
 
Michel Attal
No Relationships to Disclose
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Herve Avet-Loiseau
No Relationships to Disclose
 
Cyrille Hulin
Honoraria - Abbvie; Amgen; Celgene; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag
 
Thierry Facon
No Relationships to Disclose
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Oncopeptides; Pierre Fabre; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda